Some background: in 2019, I suffered an acute kidney injury that led to chronic kidney disease, which had stabilized
To address that gap, CMS launched a temporary Medicare GLP-1 Bridge program: starting July 1, 2026, eligible beneficiaries can access certain GLP-1 medications for about $50 per month, with eligibility tied to BMI thresholds (for example, a BMI of 35 or higher, or 27 or higher with other clinical criteria)
The "64mg" figure denotes the total lyophilised peptide load in a single multi-dose pen, not a per-dose strength, and the compound is formulated for subcutaneous administration in line with the Phase 2 and Phase 3 protocols [3]
Without insurance, the starting cost of the Wegovy pill is $149 a month for the lowest doses (1.5 milligrams and 4 milligrams)